We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

76 hedge funds and large institutions have $98M invested in Oric Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $962K | Put options by funds: $543K

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.55% less ownership

Funds ownership: 83.18% → 82.63% (-0.55%)

8% less funds holding

Funds holding: 83 → 76 (-7)

25% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 28

29% less capital invested

Capital invested by funds: $138M → $98M (-$39.6M)

41% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 17

Holders
76
Holders Change
-7
Holders Change %
-8.43%
% of All Funds
1.31%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
21
Reduced
28
Closed
17
Calls
$962K
Puts
$543K
Net Calls
+$419K
Net Calls Change
-$821K

Top Buyers

1
PM
Prosight Management
Texas
+$3.75M
2
SCM
Suvretta Capital Management
New York
+$2.56M
3
BlackRock
BlackRock
New York
+$959K
4
GCP
GSA Capital Partners
United Kingdom
+$700K
5
SCM
Silverarc Capital Management
Massachusetts
+$507K

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
-$2.96M
2
CC
Casdin Capital
New York
-$2.69M
3
Citadel Advisors
Citadel Advisors
Florida
-$752K
4
Marshall Wace
Marshall Wace
United Kingdom
-$556K
5
Charles Schwab
Charles Schwab
California
-$511K
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
76
PDT Partners
New York
– -$300K -66,945 Closed
Allspring Global Investments
77
Allspring Global Investments
North Carolina
– -$294K -65,716 Closed
Squarepoint
78
Squarepoint
New York
– -$265K -59,073 Closed
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
– -$189 -38,788 Closed
SEI Investments
80
SEI Investments
Pennsylvania
– -$67K -15,054 Closed
AQR Capital Management
81
AQR Capital Management
Connecticut
– -$56K -12,508 Closed
EGM
82
Engineers Gate Manager
New York
– -$54K -12,021 Closed
LCM
83
Laurion Capital Management
New York
– -$53K -11,940 Closed
YIH
84
Y-Intercept (HK)
Hong Kong
– -$49K -10,828 Closed
Ensign Peak Advisors
85
Ensign Peak Advisors
Utah
– -$46K -10,360 Closed
BPA
86
Beacon Pointe Advisors
California
– -$44K -10,040 Closed
Legal & General Group
87
Legal & General Group
United Kingdom
– -$11K -2,530 Closed
UBS Group
88
UBS Group
Switzerland
– -$8.29K -2,071 -94%
New York State Common Retirement Fund
89
New York State Common Retirement Fund
New York
– -$1K -283 Closed
EI
90
Ellevest Inc
New York
– -$1K -156 Closed
1 2 3
4

ORIC Hedge Fund Activity: Q3 2022 in Review

76 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q3 2022, worth a combined $98M — down 29% from $138M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ORIC and 10 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 21 added.

The largest buyer was Prosight Management, opening a new position worth an estimated $3.75M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $2.96M.

  • 76 institutional investors held Oric Pharmaceuticals (ORIC) as of Q3 2022, down from 83 in Q2 2022.
  • Funds reported $98M of Oric Pharmaceuticals stock for Q3 2022, down 29% quarter-over-quarter.
  • 10 funds opened new Oric Pharmaceuticals positions in Q3 2022 and 17 closed out, a net change of -7 holders.
  • The largest Oric Pharmaceuticals buyer in Q3 2022 was Prosight Management, an estimated $3.75M added.
  • The largest Oric Pharmaceuticals seller in Q3 2022 was ArrowMark Colorado Holdings, an estimated $2.96M sold.

Based on aggregated 13F filings for Q3 2022.